Reimagining psychoses: An agnostic approach to diagnosis

[1]  R. Yolken,et al.  Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial. , 2013, Schizophrenia bulletin.

[2]  T. Insel,et al.  Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? , 2012, Molecular Psychiatry.

[3]  Lauren E. Ethridge,et al.  Neural Activations During Auditory Oddball Processing Discriminating Schizophrenia and Psychotic Bipolar Disorder , 2012, Biological Psychiatry.

[4]  R. Murray,et al.  Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. , 2012, The American journal of psychiatry.

[5]  T. Insel.  Next-Generation Treatments for Mental Disorders , 2012, Science Translational Medicine.

[6]  J. Os,et al.  Genetic association study of the P300 endophenotype in schizophrenia , 2012, Schizophrenia Research.

[7]  R. Tandon.  The nosology of schizophrenia: toward DSM-5 and ICD-11. , 2012, Psychiatric Clinics of North America.

[8]  Mark Slifstein,et al.  The nature of dopamine dysfunction in schizophrenia and what this means for treatment. , 2012, Archives of general psychiatry.

[9]  K. Deisseroth.  Optogenetics and Psychiatry: Applications, Challenges, and Opportunities , 2012, Biological Psychiatry.

[10]  R. Malenka,et al.  The best of times, the worst of times for psychiatric disease , 2012, Nature Neuroscience.

[11]  V. Calhoun,et al.  Differences in Resting-State Functional Magnetic Resonance Imaging Functional Network Connectivity Between Schizophrenia and Psychotic Bipolar Probands and Their Unaffected First-Degree Relatives , 2012, Biological Psychiatry.

[12]  J. Shih,et al.  Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial. , 2012, The Lancet. Oncology.

[13]  F. Markowetz,et al.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.

[14]  Shannon L. Risacher,et al.  A large scale multivariate parallel ICA method reveals novel imaging–genetic relationships for Alzheimer's disease in the ADNI cohort , 2012, NeuroImage.

[15]  Godfrey Pearlson,et al.  A dimensional approach to the psychosis spectrum between bipolar disorder and schizophrenia: The Schizo-Bipolar Scale , 2011, Schizophrenia Research.

[16]  Michael F. Green,et al.  Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. , 2011, The American journal of psychiatry.

[17]  Á. Pascual-Leone,et al.  Transcranial Magnetic Stimulation: A Neuroscientific Probe of Cortical Function in Schizophrenia , 2011, Biological Psychiatry.

[18]  S. Dursun,et al.  Schizophrenia genes, epigenetics and psychoneuroimmunology therapeutics: all make sense now? , 2011, Journal of psychopharmacology.

[19]  Fred H. Gage,et al.  Modelling schizophrenia using human induced pluripotent stem cells , 2011, Nature.

[20]  T. Becker,et al.  Schizoaffective disorder–an ongoing challenge for psychiatric nosology , 2010, European Psychiatry.

[21]  N. Ridgway,et al.  Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update. , 2011, Journal of thoracic disease.

[22]  Patrick F Sullivan,et al.  The Psychiatric GWAS Consortium: Big Science Comes to Psychiatry , 2010, Neuron.

[23]  T. Suppes,et al.  Genetics and intermediate phenotypes of the schizophrenia—bipolar disorder boundary , 2010, Neuroscience & Biobehavioral Reviews.

[24]  S. Hyman,et al.  The diagnosis of mental disorders: the problem of reification. , 2010, Annual review of clinical psychology.

[25]  Christian Windischberger,et al.  Toward discovery science of human brain function , 2010, Proceedings of the National Academy of Sciences.

[26]  Michael J. Owen,et al.  The Kraepelinian dichotomy – going, going... but still not gone , 2010, British Journal of Psychiatry.

[27]  Thomas R. Insel,et al.  Endophenotypes: Bridging Genomic Complexity and Disorder Heterogeneity , 2009, Biological Psychiatry.

[28]  Vince D. Calhoun,et al.  Genetic determinants of target and novelty-related event-related potentials in the auditory oddball response , 2009, NeuroImage.

[29]  Godfrey D. Pearlson,et al.  Endophenotypes in schizophrenia: A selective review , 2009, Schizophrenia Research.

[30]  A. Farmer,et al.  Extracting a needle from a haystack: reanalysis of whole genome data reveals a readily translatable finding , 2009, Psychological Medicine.

[31]  Tyrone D. Cannon,et al.  Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study , 2009, The Lancet.

[32]  M. Keshavan,et al.  Schizophrenia, “just the facts”: What we know in 2008 Part 3: Neurobiology , 2008, Schizophrenia Research.

[33]  M. Maj,et al.  Nosological status and definition of schizophrenia: Some considerations for DSM-V and ICD-11. , 2008, Asian journal of psychiatry.

[34]  W. Griesinger.  Mental Pathology and Therapeutics , 2008 .

[35]  R. Straub,et al.  Novel Linkage to Chromosome 20p Using Latent Classes of Psychotic Illness in 270 Irish High-Density Families , 2008, Biological Psychiatry.

[36]  H. M. Praag.  Kraepelin, biological psychiatry, and beyond , 2008, European Archives of Psychiatry and Clinical Neuroscience.

[37]  Matcheri S Keshavan,et al.  Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"? , 2007, Schizophrenia bulletin.

[38]  A. Barabasi,et al.  Network medicine--from obesity to the "diseasome". , 2007, The New England journal of medicine.

[39]  A. Rzhetsky,et al.  Probing genetic overlap among complex human phenotypes , 2007, Proceedings of the National Academy of Sciences.

[40]  A. Barabasi,et al.  Human disease classification in the postgenomic era: A complex systems approach to human pathobiology , 2007, Molecular systems biology.

[41]  T. Suppes,et al.  Dimensions and the psychosis phenotype , 2007, International journal of methods in psychiatric research.

[42]  Mark R. Trusheim,et al.  Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers , 2007, Nature Reviews Drug Discovery.

[43]  David Cameron,et al.  2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial , 2007, The Lancet.

[44]  Peter Waltman,et al.  Interpreter of maladies: redescription mining applied to biomedical data analysis. , 2006, Pharmacogenomics.

[45]  M. Bear,et al.  LTP and LTD An Embarrassment of Riches , 2004, Neuron.

[46]  K. M. Evans,et al.  Searching for schizophrenia in ancient Greek and Roman literature: a systematic review , 2003, Acta psychiatrica Scandinavica.

[47]  I. Gottesman,et al.  The endophenotype concept in psychiatry: etymology and strategic intentions. , 2003, The American journal of psychiatry.

[48]  R. Kendell,et al.  Distinguishing between the validity and utility of psychiatric diagnoses. , 2003, The American journal of psychiatry.

[49]  P. Meehl.  Bootstraps taxometrics. Solving the classification problem in psychopathology. , 1995, The American psychologist.

[50]  J. Kasanin.  The acute schizoaffective psychoses. 1933. , 1994, The American journal of psychiatry.

[51]  K. Kendler.  Toward a scientific psychiatric nosology. Strengths and limitations. , 1990, Archives of general psychiatry.

[52]  R. Dawes,et al.  Heuristics and Biases: Clinical versus Actuarial Judgment , 2002 .

[53]  G. Berríos,et al.  The early development of Kraepelin's ideas on classification: a conceptual history , 1988, Psychological Medicine.

[54]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[55]  G. Klerman,et al.  The dexamethasone suppression test: An overview of its current status in psychiatry , 1987 .

[56]  Sedler Mj.  The legacy of Ewald Hecker: a new translation of "Die Hebephrenie". Translated by Marie-Louise Schoelly. , 1985 .

[57]  D. Jeste,et al.  Did schizophrenia exist before the eighteenth century? , 1985, Comprehensive psychiatry.

[58]  M. Taylor,et al.  Importance of schizophrenic symptoms in the diagnosis of mania. , 1981, The American journal of psychiatry.

[59]  B. Carroll,et al.  A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. , 1981, Archives of general psychiatry.

[60]  市川 潤,et al.  Karl Kahlbaum;Die Katatonie oder das Spannungsirresein--Eine klinische Form psychischer Krankheit〔August Hirschwald,Berlin,1874〕 , 1979 .

[61]  Emil Kraepelin,et al.  Manic-depressive insanity and paranoia , 1976 .

[62]  E. Robins,et al.  Research diagnostic criteria. , 1975, Psychopharmacology bulletin.

[63]  J. Strauss,et al.  The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs. , 1974, Schizophrenia bulletin.

[64]  J. Strauss,et al.  Are there pathognomonic symptoms in schizophrenia? An empiric investigation of Schneider's first-rank symptoms. , 1973, Archives of general psychiatry.

[65]  J. Copeland,et al.  Diagnostic criteria of American and British psychiatrists. , 1971, Archives of general psychiatry.

[66]  S. Guze,et al.  Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. , 1970, The American journal of psychiatry.

[67]  A. Meyer.  Psychobiology : a science of man , 1957 .

[68]  J. Kasanin.  THE ACUTE SCHIZOAFFECTIVE PSYCHOSES , 1933 .